Literature DB >> 10369714

Relation between severity of liver disease and renal oxygen consumption in patients with cirrhosis.

A Gadano1, R Moreau, J Heller, C Chagneau, F Vachiéry, C Trombino, A Elman, C Denié, D Valla, D Lebrec.   

Abstract

BACKGROUND: Worsening cirrhosis may lead to increased renal O2 metabolism caused by activation of neurohumoral antinatriuretic substances. AIMS: To evaluate the relation between the severity of liver disease, sodium excretion, and neurohumoral antinatriuretic substances on the one hand and renal O2 metabolism on the other in patients with cirrhosis.
METHODS: Renal O2 consumption and haemodynamics as well as plasma concentrations of noradrenaline, renin, and aldosterone were measured. Investigations were performed in 14 patients with Pugh's grade A, 43 with grade B, and 29 with grade C liver disease.
RESULTS: Renal O2 consumption significantly increased with the severity of cirrhosis (grade A, 8.9 (1.6); grade B, 15.5 (1.3); grade C, 18.0 (1.5) ml/min/m2). Plasma concentrations of noradrenaline, renin, and aldosterone significantly increased while mean arterial presssure and systemic vascular resistance significantly decreased with the severity of the disease. A significant inverse correlation was found between renal O2 consumption and sodium excretion. A significant direct correlation was found between plasma levels of noradrenaline and aldosterone on the one hand and renal O2 consumption on the other. Renal blood flow and the glomerular filtration rate did not differ significantly between patients with grade C and grade A or B disease.
CONCLUSIONS: This study shows for the first time that, in patients with cirrhosis, worsening of the disease is associated with an increase in renal O2 consumption. The results suggest that increased renal O2 consumption is due to renal tubular sodium retention caused by increased levels of neurohumoral antinatriuretic substances. This neurohumoral activation is related to cirrhosis induced vasodilation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369714      PMCID: PMC1727557          DOI: 10.1136/gut.45.1.117

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

Review 1.  Transduction of antinatriuretic signals in renal proximal tubular cells in cirrhosis: introduction to novel approaches to the treatment of sodium retention.

Authors:  R Moreau; D Lebrec
Journal:  J Hepatol       Date:  1998-06       Impact factor: 25.083

Review 2.  The hepatorenal syndrome.

Authors:  K Moore
Journal:  Clin Sci (Lond)       Date:  1997-05       Impact factor: 6.124

3.  Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.

Authors:  D Lebrec; N Giuily; A Hadengue; V Vilgrain; R Moreau; T Poynard; A Gadano; C Lassen; J P Benhamou; S Erlinger
Journal:  J Hepatol       Date:  1996-08       Impact factor: 25.083

4.  Transection of the oesophagus for bleeding oesophageal varices.

Authors:  R N Pugh; I M Murray-Lyon; J L Dawson; M C Pietroni; R Williams
Journal:  Br J Surg       Date:  1973-08       Impact factor: 6.939

5.  Changes in plasma renin activity in cirrhosis: a reappraisal based on studies in 67 patients and "low-renin" cirrhosis.

Authors:  S P Wilkinson; I K Smith; R Williams
Journal:  Hypertension       Date:  1979 Mar-Apr       Impact factor: 10.190

6.  Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function.

Authors:  M Bernardi; F Trevisani; C Santini; G Zoli; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Hepatology       Date:  1983 Jan-Feb       Impact factor: 17.425

7.  Renal neural activity in hepatorenal syndrome.

Authors:  G F DiBona
Journal:  Kidney Int       Date:  1984-05       Impact factor: 10.612

8.  Renin, aldosterone and renal haemodynamics in cirrhosis with ascites.

Authors:  V Arroyo; J Bosch; M Mauri; J Viver; A Mas; F Rivera; J Rodes
Journal:  Eur J Clin Invest       Date:  1979-02       Impact factor: 4.686

Review 9.  Catecholamine measurements by high-performance liquid chromatography.

Authors:  P Hjemdahl
Journal:  Am J Physiol       Date:  1984-07

10.  Potential role of increased sympathetic activity in impaired sodium and water excretion in cirrhosis.

Authors:  D G Bichet; V J Van Putten; R W Schrier
Journal:  N Engl J Med       Date:  1982-12-16       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.